Mérieux Equity Partners

Developer of a pacing device designed to maintain cardiac rhythm. The company's implanted leadless pacemakers incorporate a self-sustaining power patented technology harvesting the heart's kinetic energy and bringing disruptive technologies to conventional leadless pacemakers, enabling patients and healthcare professionals with cost-effective alternatives that will revolutionize patients' quality of life.

Dental Monitoring SAS is a Paris-based company established in 2015 that specializes in providing a web-based orthodontic monitoring solution. This innovative platform enables patients to capture and transmit images of their tooth movements through mobile devices, facilitating remote communication with orthodontists. The technology allows orthodontists to monitor and manage treatment plans effectively without the need for frequent in-office visits. Since its inception, the company has experienced significant growth, expanding its team to over 200 professionals across Europe, the USA, Australia, Hong Kong, and Singapore. Founded by Philippe Salah, who has extensive academic credentials in bioinformatics and biophysics, Dental Monitoring is at the forefront of integrating digital solutions into orthodontic care.

Swixx Biopharma fully represents biopharma companies in the CEE. It is designed to fully replace biopharma, OTC, and medical device multinationals’ subsidiaries or business units in those countries, or therapeutic areas of CEE, that the multinational chooses not to enter, or to exit. The company was founded in 2014 and is registered in Baar, Switzerland. It has 100%-owned affiliates in Albania, Bosnia & Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Greece, Hungary, Kosovo, Latvia, Lithuania, North Macedonia, Montenegro, Poland, Romania, Russia, Serbia, Slovakia, and Slovenia.

AcuSurgical is a startup developing a robotic assistant for vitreo-retinal surgery.

Plantex is a manufacturer of plant extracts for nutraceutical, food, animal nutrition, and cosmetic use. Plantex combines its knowledge of plants and its skill as a producer to meet your requirements for authenticity, efficiency, and innovation.

TARA Biosystems, Inc. specializes in organ-on-a-chip technology, focusing on the development of human cardiac tissue models for drug discovery and safety assessment. Founded in 2014 and based in the United States, the company utilizes human stem cell-derived cardiac tissue that is matured to physiologically relevant adult-like levels. This approach allows TARA Biosystems to offer high-fidelity solutions that provide direct measures of cardiac functionality, including contractile force. By creating predictive in vitro models, TARA Biosystems aims to enhance the efficiency and reliability of new therapy development, facilitating advancements in translational medicine and toxicology.

Ceva Sante Animale S.A. engages in the research, development, production, and marketing of pharmaceutical products and vaccines for companion and farm animals. They work with welfare and social programmes around the world to bring this vision to life – anywhere their products and know-how can make a difference and with all kinds of partners. From Uganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where they supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs.

DDMEDICA is a medical product company based in France dedicated to adding innovative and personalized responses for patients who suffer from rare diseases or serious medical conditions. Currently, there are many unmet medical needs for products to be used together with, or instead of, drugs in niche markets or rare diseases. Addressing this unique market requires a specific know-how and a dedicated European organisation. ADDMEDICA is capable of targeting such medical products throughout the world and to procure them for health professionals and/or patients.

Mabtech AB is a biotechnology company based in Stockholm, Sweden, founded in 1986. The company specializes in the development, manufacturing, and marketing of monoclonal antibodies and various assay kits, including those for enzyme-linked immunoassays such as ELISA, ELISpot, and FluoroSpot. Mabtech's product range includes monoclonal antibodies for a variety of applications, as well as specialized kits for detecting cytokines and other immunological molecules in biological samples from multiple species, including humans and various animals. The company aims to support the global scientific community by providing efficient tools that streamline the biomedical research process. Mabtech operates internationally, with locations in the United States, Australia, Germany, and France, and offers its products online. It is a subsidiary of Mabtech Group AB.